Gilead Sciences (GILD) Work In Process (2009 - 2015)
Gilead Sciences (GILD) posted Work In Process of $542.0 million for Q4 2015, up 8.4% quarter-over-quarter from $500.0 million in Q4 2014, and up 8.4% year-on-year from $500.0 million in Q4 2014.
Gilead Sciences (GILD) Work In Process (2009 - 2015) Analysis & Trends
Gilead Sciences (GILD) has reported Work In Process for 7 consecutive years, with $542.0 million the latest figure, recorded in Q4 2015.
- Work In Process for Q4 2015 came in at $542.0 million, up 8.4% year-over-year; the trailing twelve-month figure through Dec 2015 was $542.0 million (up 8.4% YoY), and the FY2015 annual result was $542.0 million, up 8.4% from the prior year.
- Work In Process was $542.0 million for Q4 2015 at Gilead Sciences, up from $500.0 million in the prior quarter.
- Over five years, Work In Process peaked at $563.9 million in Q2 2014 and troughed at $175.5 million in Q3 2011.
- Average Work In Process over 5 years is $398.7 million, with a median of $412.9 million recorded in 2013.
- Year-over-year, Work In Process slumped 55.28% in 2011 and climbed 21.08% in 2014.
- Over 5 years, Work In Process stood at $466.5 million in 2011, then decreased by 23.15% to $358.5 million in 2012, then rose by 15.18% to $412.9 million in 2013, then gained by 21.08% to $500.0 million in 2014, then gained by 8.4% to $542.0 million in 2015.
- Per Business Quant data, the three most recent Work In Process figures were $542.0 million in Q4 2015, $500.0 million in Q4 2014, and $563.9 million in Q2 2014.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 542.00 Mn |
| Dec 31, 2014 | 500.00 Mn |
| Jun 30, 2014 | 563.88 Mn |
| Dec 31, 2013 | 412.95 Mn |
| Dec 31, 2012 | 358.53 Mn |
| Dec 31, 2011 | 466.50 Mn |
| Sep 30, 2011 | 175.55 Mn |
| Jun 30, 2011 | 271.64 Mn |
| Mar 31, 2011 | 296.87 Mn |
| Dec 31, 2010 | 454.65 Mn |
| Sep 30, 2010 | 392.54 Mn |
| Dec 31, 2009 | 392.04 Mn |